Fibroblast remodeling of adsorbed collagen type IV is altered in contact with cancer cells

Histology and Histopathology

Volumn 23, Issue 7, 2008, Pages 833-842

  Maneva Radicheva, L ^a,d   Ebert, U ^b   Dimoudis, N ^b   Altankov, G ^a,c  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d Medical Faculty   (United Kingdom)

Author keywords

Adsorbed collagen IV reorganization; Fibroblasts and cancer cells co culture; MMP 2

Indexed keywords

COLLAGEN TYPE 4; GELATINASE A; INTEGRIN;

ADENOCARCINOMA; ADSORPTION; ARTICLE; COCULTURE; CYTOLOGY; CYTOSKELETON; ENZYME ACTIVATION; FIBROBLAST; FLUORESCENCE MICROSCOPY; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; SKIN;

ADENOCARCINOMA; ADSORPTION; COCULTURE TECHNIQUES; COLLAGEN TYPE IV; CYTOSKELETON; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; INTEGRINS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MICROSCOPY, FLUORESCENCE; SKIN;

EID: 44449109714     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Altankov G., Grinnell F. and Groth Th. (1996). Studies on the biocompatibility of materials: Fibroblast reorganization of substratum-bound fibronectin on surfaces varying in wettability, J. Biomed. Mat. Res. 30, 385-391.
2. Amano S., Akutsu N., Matsunga Y., Nishiyama T., Champliaud M.F., Burgeson R.E. and Adachi E. (2001). Importance of balance between extracellular matrix synthesis and degradation in basement membrane formation. Exp. Cell. Res. 271, 249-262.
3. Ayad S., Boot-Handford R.P., Humphries M.J., Kadler K.E. and Shutteleworth C.A. (1994). The extracellular matrix facts book. Academic Press. Harcourt Brace & Company Publishers. pp 617.
4. Beningo A., Dembo M. and Wang Y. (2004). Responses of fibroblasts to anchorage of dorsal extracellular matrix receptors. Proc. Natl. Acad. Sci. USA 101, 18024-18029.
5. Bernardo M. and Fridman R. (2003). TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem. J. 374, 739-45
6. Bhowmick N.A., Neilson E.G. and Moses H.L. (2004). Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337.
7. Boyd R.S. and Balkwill F.R. (1999). MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br. J. Cancer 80, 315-321.
8. Chernousov M., Stahl R. and Carey D. (1998). Schwann cells use a novel collagen-dependent mechanism for fibronectin fibril assembly. J. Cell. Sci. 111, 2763-77.
9. Christopher R.A., Kowalczyk A.P. and McKeown-Longo P.J. (1997). Localization of fibronectin matrix assembly sites on fibroblasts and endothelial cells. J. Cell Biol. 110, 569-581.
10. Clark K., Pankov R., Travis M., Askari J., Mould A., Craig S., Newham P., Yamada K. and Humphries M. (2005). A specific alpha5beta1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. J. Cell Sci. 118, 291-300.
11. Danen E. and Yamada K. (2001). Fibronectin, integrins and growth control. J. Cell. Physiol. 189, 1-13.
12. DeClerck Y., Mercurio A., Stack M., Chapman H., Zutter M., Muschel R., Raz A., Matrisian L., Sloane B., Noel A., Hendrix M., Coussens L. and Padarathsingh M. (2004). Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am. J. Pathol. 164, 1131-1139
13. Deryugina E., Bourdon M., Reisfeld R. and Strongin A. (1998). Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res. 58, 3743-3750.
14. Dzamba B., Wu H., Jaenisch R. and Peters D. (1993). Fibronectin binding site in type I collagen regulates fibronectin fibril formation. J. Cell Biol. 121, 1165-1172.
15. Felding-Habermann B. (2003). Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis 20, 203-213.
16. Fenhalls G., Geyp M., Dent D.M. and Parker M.I. (1999). Breast tumor cell-induced down regulation of type I collagen mRNA in fibroblasts. Br. J. Cancer 81, 1142-1149.
17. Fleischmajer R., Perlish J.S., MacDonald E.D. 2nd, Schechter A., Murdoch A.D., Iozzo R.V. and Yamada Y. (1998). There is binding of collagen IV to beta 1 integrin during early skin basement membrane assembly. Ann. NY Acad. Sci. 857, 212-227.
18. Golubkov V.S. and Strongin A.Y. (2007). Proteolysis-driven oncogenesis. Cell Cycle 6, 147-50.
19. Grinnell F. (1986). Focal adhesion sites and the removal of substratum-bound fibronectin. J. Cell Biol. 103, 2697-706.
20. Humphries J., Byron A. and Humphries M. (2006). Integrin ligands at a glance. J. Cell Sci. 119, 3901-3903.
21. Humphries M., Travis M., Clark K. and Mould A. (2004). Mechanisms of integration of cells and extracellular matrices by integrins. Biochem. Soc. Trans. 32, 822-825.
22. Jiang Y., Goldberg D.I. and Shi Y.E. (2002). Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21, 2245-2252.
23. Kalluri R. (2003). Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3, 422-33.
24. Kolkenbrock H., Hecker-Kia A., Orgel D., Ulrich N. and Will H. (1997). Activation of progelatinase A and progelatinaseA/TIMP-2 complex by membrane type 2-matrix metalloproteinase. J. Biol. Chem. 378, 71-76.
25. Kuhn K. (1994). Basement membrane (typeIV) collagen. Matrix Biol. 14, 439-445.
26. Larsen M., Artym V., Green J., Yamada K. (2006). The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr. Opin. Cell Biol. 18, 463-71.
27. Lee A., Akers K., Collier M., Li L., Eisen A. and Seltzer J. (1997). Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc. Natl. Acad. Sci. USA 94, 4424-4429.
28. Luo B. and Springer T. (2006). Integrin structures and conformational signaling. Curr. Opin. Cell Biol. 18, 579-86.
29. Lynch C.C. and Matrisian L.M. (2002). Matrix metalloproteinases in tumor-host cell communication. Differentiation 70, 561-573.
30. Mao Y. and Schwarzbauer J. (2005). Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix. Biol. 24, 389-399.
31. Mitev V. and Miteva L. (1999). Signal transduction in keratinocytes. Exp. Dermatol. 8, 96-108.
32. Myohanen H. and Vaheri A. (2004). Regulation and interactions in the activation of cell-associated plasminogen. Cell. Mol. Life Sci. 61, 2840-2858.
33. Saad S., Gottlied D.J., Bradstock K.F., Overall C.M. and Bendall L.J. (2002). Cancer cell-associated fibronectin induced release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Research 62, 283-289.
34. Sato T., Iwai M., Sakai T., Sato H., Seiki M., Mori Y. and Ito A. (1999). Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Br. J. Cancer 80, 1137-1143.
35. Sato T., Sakai T., Noguchi Y., Takita M., Hirakawa S. and Ito A. (2004). Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol. Oncol. 92, 47-56.
36. Silletti S., Paku S. and Raz A. (1998). Autocrine motility factor and the extracellular matrix. II. Degradation or remodeling of substrate components directs the motile response of tumor cells. Int. J. Cancer 76, 129-135.
37. Sottile J. and Hocking D. (2002). Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol. Biol. Cell. 13, 3546-3559.
38. Stamenkovic I. (2003). Extracellular matrix remodeling: the role of matrix metalloproteinases. J. Pathol. 200, 448-464.
39. Steffensen B., Xu X., Martin P. and Zardeneta G. (2002). Human fibronectin and MMP-2 collagen binding domains compete for collagen binding sites and modify cellular activation of MMP-2. Matrix Biol. 5, 399-414.
40. Stewart D.A., Cooper C. and Sikes R. (2004). Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod. Biol. Endocrinol. 2, 2.
41. Strongin A., Collier I., Bannikov G., Marmer B., Grant G. and Goldberg G. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270, 5331-5338.
42. Stupack D. and Cheresh D. (2002). Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 115, 3729-38.
43. Tiger C., Fougerousse F., Grundstrom G., Velling T., and Gullberg D. (2001). alpha11 beta1 integrin is a receptor for interstitial collagens involved in cell migration, and collagen reorganization on Mesenchymal nonmuscle cells. Dev. Biol. 237, 116-129.
44. Tzoneva R., Groth T., Altankov G. and Paul D. (2002). Remodeling of fibrinogen by endothelial cells in dependence on fibronectin matrix assembly. Effect of substratum wettability. J. Mater. Sci. Mater. Med. 13, 1235-44.
45. Vanacore R., Friedman D., Ham A., Sundaramoorthy M. and Hudson B. (2005). Identification of S-hydroxylysyl-methionine as the covalent cross-link of the noncollagenous (NC1) hexamer of the alpha1alpha1alpha2 collagen IV network: a role for the post-translational modification of lysine 211 to hydroxylysine 211 in hexamer assembly. J. Biol. Chem. 280, 29300-29310.
46. Velling T., Risteli J., Wennerberg K., Mosher D. and Johansson S. (2002). Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J. Biol. Chem. 277, 37377-81
47. Watt F.M. (2002). Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J. 21, 3919-26.
48. Wei Y., Tang C., Kim Y., Robillard L., Zhang F., Kugler M. and Chapman H.A. (2007). Urokinase receptors are required for alpha 5beta 1 integrin-mediated signaling in tumor cells. J. Biol. Chem. 282, 3929-39
49. Wierzbicka-Patynowski I. and Schwarzbauer J. (2003). The ins and outs of fibronectin matrix assembly. J. Cell Sci.116, 3269-76.
50. Wong S. and Hynes R. (2006). Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5, 812-7.
51. Wu C., Keivens V.M., O'Tool T.E., McDonald J.A. and Ginsberg M.H. (1995). Integrin activation and cytoskeletal interaction are essential for the assembly of fibronectin matrix. Cell 83, 715-724.
52. Yi M. and Ruoslahti E. (2001). A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc. Natl. Acad. Sci. USA 98, 620-624.
53. Zigrino P., Drescher C. and Mauch C. (2000). Collagen-induced pro-MMP-2 activation by MT1-MMP in human dermal fibroblasts and possible role of α2ß1 integrins. Eur. J. Cell Biol. 80, 68-77.
54. Zoppi N., Gardella R., De Paepe A., Barlati S. and Colombi M. (2004). Human Fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate α2ß2 integrin, and recruit αvß3 instead of α5ß1 integrin. J. Biol. Chem. 279, 18157-18168.